- Home
- MNPR vs PLBC Comparison
MNPR vs PLBC Comparison
Compare MNPR & PLBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNPR
- PLBC
- Stock Information
- Founded
- MNPR 2014
- PLBC 1980
- Country
- MNPR United States
- PLBC United States
- Employees
- MNPR N/A
- PLBC N/A
- Industry
- MNPR Biotechnology: Pharmaceutical Preparations
- PLBC Finance Companies
- Sector
- MNPR Health Care
- PLBC Finance
- Exchange
- MNPR Nasdaq
- PLBC Nasdaq
- Market Cap
- MNPR 248.8M
- PLBC 236.7M
- IPO Year
- MNPR 2019
- PLBC 2005
- Fundamental
- Price
- MNPR $66.64
- PLBC $43.33
- Analyst Decision
- MNPR Strong Buy
- PLBC Buy
- Analyst Count
- MNPR 11
- PLBC 4
- Target Price
- MNPR $68.60
- PLBC $57.00
- AVG Volume (30 Days)
- MNPR 44.1K
- PLBC 12.5K
- Earning Date
- MNPR 11-07-2025
- PLBC 10-15-2025
- Dividend Yield
- MNPR N/A
- PLBC 2.65%
- EPS Growth
- MNPR N/A
- PLBC 1.22
- EPS
- MNPR N/A
- PLBC 4.86
- Revenue
- MNPR N/A
- PLBC $84,003,000.00
- Revenue This Year
- MNPR N/A
- PLBC $22.16
- Revenue Next Year
- MNPR N/A
- PLBC $17.58
- P/E Ratio
- MNPR N/A
- PLBC $9.33
- Revenue Growth
- MNPR N/A
- PLBC 6.85
- 52 Week Low
- MNPR $3.90
- PLBC $37.69
- 52 Week High
- MNPR $68.18
- PLBC $51.33
- Technical
- Relative Strength Index (RSI)
- MNPR 80.24
- PLBC 48.99
- Support Level
- MNPR $42.51
- PLBC $42.97
- Resistance Level
- MNPR $45.78
- PLBC $46.59
- Average True Range (ATR)
- MNPR 4.36
- PLBC 0.97
- MACD
- MNPR 2.91
- PLBC -0.12
- Stochastic Oscillator
- MNPR 95.65
- PLBC 19.90
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
About PLBC Plumas Bancorp
Plumas Bancorp provides various banking products and services in Northeastern California and Northwestern Nevada. It provides various deposit products such as checking, interest-bearing checking, business sweep, public funds sweep, savings, time deposit, and retirement accounts. The bank's loan portfolio consists of commercial real estate loans; commercial and industrial loans; consumer loans; agricultural loans; residential real estate loans, and construction and land development loans. The bank generates revenue from loans and investment securities in its portfolio and, to a lesser extent, service fees.